Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.

Storebø OJ, Elmose Andersen M, Skoog M, Joost Hansen S, Simonsen E, Pedersen N, Tendal B, Callesen HE, Faltinsen E, Gluud C.

Cochrane Database Syst Rev. 2019 Jun 21;6:CD008223. doi: 10.1002/14651858.CD008223.pub3. Review.

PMID:
31222721
2.

Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses.

Krogh HB, Storebø OJ, Faltinsen E, Todorovac A, Ydedahl-Jensen E, Magnusson FL, Holmskov M, Gerner T, Gluud C, Simonsen E.

BMJ Open. 2019 Mar 30;9(3):e026478. doi: 10.1136/bmjopen-2018-026478.

3.

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look.

Faltinsen E, Zwi M, Castells X, Gluud C, Simonsen E, Storebø OJ.

BMJ Evid Based Med. 2019 Jun;24(3):99-102. doi: 10.1136/bmjebm-2018-111110. Epub 2018 Dec 10. No abstract available.

PMID:
30530806
4.

Unbalanced risk-benefit analysis of ADHD drugs.

Faltinsen EG, Gluud C, Simonsen E, Zwi M, Storebø OJ.

Lancet Psychiatry. 2018 Nov;5(11):870. doi: 10.1016/S2215-0366(18)30334-1. Epub 2018 Oct 26. No abstract available.

PMID:
30401440
5.

The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.

Storebø OJ, Faltinsen E, Zwi M, Simonsen E, Gluud C.

Clin Pharmacol Ther. 2018 Oct;104(4):606-609. doi: 10.1002/cpt.1149. Epub 2018 Jul 13.

PMID:
30006934
6.

Childhood ADHD and treatment outcome: the role of maternal functioning.

Rasmussen PD, Storebø OJ, Shmueli-Goetz Y, Bojesen AB, Simonsen E, Bilenberg N.

Child Adolesc Psychiatry Ment Health. 2018 Jun 14;12:31. doi: 10.1186/s13034-018-0234-3. eCollection 2018.

7.

Attachment as a Core Feature of Resilience: A Systematic Review and Meta-Analysis.

Darling Rasmussen P, Storebø OJ, Løkkeholt T, Voss LG, Shmueli-Goetz Y, Bojesen AB, Simonsen E, Bilenberg N.

Psychol Rep. 2019 Aug;122(4):1259-1296. doi: 10.1177/0033294118785577. Epub 2018 Jun 29.

PMID:
29958512
8.

Training, executive, attention and motor skills (TEAMS) training versus standard treatment for preschool children with attention deficit hyperactivity disorder: a randomised clinical trial.

Vibholm HA, Pedersen J, Faltinsen E, Marcussen MH, Gluud C, Storebø OJ.

BMC Res Notes. 2018 Jun 8;11(1):366. doi: 10.1186/s13104-018-3478-3.

9.

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2018 May 9;5:CD012069. doi: 10.1002/14651858.CD012069.pub2. Review.

10.

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder.

Faltinsen EG, Storebø OJ, Gluud C.

Eur Child Adolesc Psychiatry. 2019 Jan;28(1):145-146. doi: 10.1007/s00787-018-1164-6. Epub 2018 May 9. No abstract available.

PMID:
29744668
11.

Network meta-analysis: the highest level of medical evidence?

Faltinsen EG, Storebø OJ, Jakobsen JC, Boesen K, Lange T, Gluud C.

BMJ Evid Based Med. 2018 Apr;23(2):56-59. doi: 10.1136/bmjebm-2017-110887. Epub 2018 Mar 14. No abstract available.

PMID:
29595131
12.

Evidensen for medisinsk behandling av AD/HD er usikker.

Storebø OJ.

Tidsskr Nor Laegeforen. 2018 Mar 16;138(6). doi: 10.4045/tidsskr.18.0182. Print 2018 Mar 20. Norwegian. No abstract available.

PMID:
29557129
Free Article
13.

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.

Boesen K, Saiz LC, Erviti J, Storebø OJ, Gluud C, Gøtzsche PC, Jørgensen KJ.

Evid Based Med. 2017 Aug;22(4):143-147. doi: 10.1136/ebmed-2017-110716. Epub 2017 Jul 13.

14.

Reviews and Meta-analyses of Psychotherapy Efficacy for Borderline Personality Disorder.

Faltinsen EG, Kongerslev M, Storebø OJ.

JAMA Psychiatry. 2017 Aug 1;74(8):853-854. doi: 10.1001/jamapsychiatry.2017.1397. No abstract available.

PMID:
28636688
15.

Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.

Holmskov M, Storebø OJ, Moreira-Maia CR, Ramstad E, Magnusson FL, Krogh HB, Groth C, Gillies D, Zwi M, Skoog M, Gluud C, Simonsen E.

PLoS One. 2017 Jun 15;12(6):e0178187. doi: 10.1371/journal.pone.0178187. eCollection 2017. Review.

16.

Evidence on methylphenidate in children and adolescents with ADHD is in fact of 'very low quality'.

Storebø OJ, Zwi M, Krogh HB, Moreira-Maia CR, Holmskov M, Gillies D, Groth C, Simonsen E, Gluud C.

Evid Based Ment Health. 2016 Nov;19(4):100-102. doi: 10.1136/eb-2016-102499. Epub 2016 Oct 8.

PMID:
27935808
17.

Response to "Trust, but verify" by Banaschewski et al.

Storebø OJ, Zwi M, Moreira-Maia CR, Skoog M, Camilla G, Gillies D, Simonsen E, Gluud C.

Z Kinder Jugendpsychiatr Psychother. 2016 Sep;44(5):334-335. No abstract available.

PMID:
27658627
18.

Methylphenidate for Attention-Deficit/Hyperactivity Disorder-Reply.

Storebø OJ, Simonsen E, Gluud C.

JAMA. 2016 Sep 6;316(9):995. doi: 10.1001/jama.2016.10300. No abstract available.

PMID:
27599345
19.

Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Storebø OJ, Simonsen E, Gluud C.

JAMA. 2016 May 10;315(18):2009-10. doi: 10.1001/jama.2016.3611.

PMID:
27163989
20.

The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed.

Storebø OJ, Simonsen E, Gluud C.

Eur Child Adolesc Psychiatry. 2016 Sep;25(9):1037-8. doi: 10.1007/s00787-016-0855-0. Epub 2016 Apr 30. No abstract available.

PMID:
27138912
21.

Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.

Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, Nilausen TD, Magnusson FL, Zwi M, Gillies D, Rosendal S, Groth C, Rasmussen KB, Gauci D, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

BMJ. 2015 Nov 25;351:h5203. doi: 10.1136/bmj.h5203. Review.

22.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Review.

PMID:
26599576
23.

Attachment Competences in Children With ADHD During the Social-Skills Training and Attachment (SOSTRA) Randomized Clinical Trial.

Storebø OJ, Skoog M, Rasmussen PD, Winkel P, Gluud C, Pedersen J, Thomsen PH, Simonsen E.

J Atten Disord. 2015 Oct;19(10):865-71. doi: 10.1177/1087054713520220. Epub 2014 Feb 14.

PMID:
24532801
24.

The Association Between ADHD and Antisocial Personality Disorder (ASPD): A Review.

Storebø OJ, Simonsen E.

J Atten Disord. 2016 Oct;20(10):815-24. doi: 10.1177/1087054713512150. Epub 2013 Nov 27. Review.

PMID:
24284138
25.

Is ADHD an early stage in the development of borderline personality disorder?

Storebø OJ, Simonsen E.

Nord J Psychiatry. 2014 Jul;68(5):289-95. doi: 10.3109/08039488.2013.841992. Epub 2013 Oct 11. Review.

PMID:
24117059
26.

Association Between Insecure Attachment and ADHD: Environmental Mediating Factors.

Storebø OJ, Rasmussen PD, Simonsen E.

J Atten Disord. 2016 Feb;20(2):187-96. doi: 10.1177/1087054713501079. Epub 2013 Sep 23. Review.

PMID:
24062279
27.

Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD--the randomised SOSTRA trial.

Storebø OJ, Gluud C, Winkel P, Simonsen E.

PLoS One. 2012;7(6):e37280. doi: 10.1371/journal.pone.0037280. Epub 2012 Jun 20.

28.

The effects of cognitive therapy versus 'no intervention' for major depressive disorder.

Jakobsen JC, Hansen JL, Storebø OJ, Simonsen E, Gluud C.

PLoS One. 2011;6(12):e28299. doi: 10.1371/journal.pone.0028299. Epub 2011 Dec 9.

29.

Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Storebø OJ, Skoog M, Damm D, Thomsen PH, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008223. doi: 10.1002/14651858.CD008223.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Jun 21;6:CD008223.

PMID:
22161422
30.

The effects of cognitive therapy versus 'treatment as usual' in patients with major depressive disorder.

Jakobsen JC, Lindschou Hansen J, Storebø OJ, Simonsen E, Gluud C.

PLoS One. 2011;6(8):e22890. doi: 10.1371/journal.pone.0022890. Epub 2011 Aug 4. Review.

31.

Supplemental Content

Loading ...
Support Center